Puma Biotechnology, Inc.
Puma Biotechnology, Inc. (PBYI) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · PBYI · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
20
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Puma Biotechnology, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
PBYI insider buying and selling by quarter
PBYI insider selling · PBYI insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · PBYI ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
PBYI executive sell shares · PBYI board member insider trading · PBYI insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Feb 18, 2026 | AUERBACH ALAN H President and CEO · Director | Award | 159,778 | — | Form 4 |
| Feb 18, 2026 | HUNT DOUGLAS M See Remarks | Award | 49,394 | — | Form 4 |
| Feb 18, 2026 | NOUGUES MAXIMO F CFO | Award | 46,739 | — | Form 4 |
| Jan 6, 2026 | AUERBACH ALAN H President and CEO · Director | Sale | 16,938 | $99K | Form 4 |
| Jan 7, 2026 | AUERBACH ALAN H President and CEO · Director | Sale | 18,012 | $106K | Form 4 |
| Jan 6, 2026 | HUNT DOUGLAS M See Remarks | Sale | 3,973 | $23K | Form 4 |
| Jan 7, 2026 | HUNT DOUGLAS M See Remarks | Sale | 5,014 | $29K | Form 4 |
| Jan 6, 2026 | NOUGUES MAXIMO F CFO | Sale | 4,540 | $27K | Form 4 |
| Jan 7, 2026 | NOUGUES MAXIMO F CFO | Sale | 6,405 | $38K | Form 4 |
| Nov 11, 2025 | MILLER MICHAEL PATRICK Director | Sale | 20,000 | $97K | Form 4 |
| Jul 18, 2025 | Cesano Alessandra Director | Sale | 27,000 | $91K | Form 4 |
| Jul 8, 2025 | NOUGUES MAXIMO F CFO | Sale | 5,587 | $20K | Form 4 |
| Jul 9, 2025 | NOUGUES MAXIMO F CFO | Sale | 3,935 | $14K | Form 4 |
| Jul 8, 2025 | HUNT DOUGLAS M See Remarks | Sale | 4,374 | $15K | Form 4 |
| Jul 9, 2025 | HUNT DOUGLAS M See Remarks | Sale | 3,443 | $12K | Form 4 |
| Jul 8, 2025 | AUERBACH ALAN H President and CEO · Director | Sale | 25,592 | $90K | Form 4 |
| Jul 9, 2025 | AUERBACH ALAN H President and CEO · Director | Sale | 21,580 | $76K | Form 4 |
| Jun 13, 2025 | WILSON TROY EDWARD Director | Sale | 10,800 | $37K | Form 4 |
| Jun 13, 2025 | Stuglik Brian M Director | Sale | 8,100 | $27K | Form 4 |
| Jun 13, 2025 | Senderowicz Adrian Director | Sale | 27,000 | $92K | Form 4 |
| Jun 13, 2025 | MOYES JAY M Director | Sale | 22,000 | $75K | Form 4 |
| Jun 13, 2025 | Dorval Allison Director | Sale | 11,610 | $39K | Form 4 |
| Jun 13, 2025 | Cesano Alessandra Director | Sale | 12,150 | $41K | Form 4 |
| Jun 11, 2025 | MILLER MICHAEL PATRICK Director | Award | 27,000 | — | Form 4 |
| Jun 11, 2025 | Senderowicz Adrian Director | Award | 27,000 | — | Form 4 |
AUERBACH ALAN H
President and CEO · Director
Date
Feb 18
Shares
159,778
Price
—
Value
—
AUERBACH ALAN H
President and CEO · Director
Date
Jan 6
Shares
16,938
Price
$5.84
Value
$99K
AUERBACH ALAN H
President and CEO · Director
Date
Jan 7
Shares
18,012
Price
$5.88
Value
$106K
AUERBACH ALAN H
President and CEO · Director
Date
Jul 8
Shares
25,592
Price
$3.53
Value
$90K
AUERBACH ALAN H
President and CEO · Director
Date
Jul 9
Shares
21,580
Price
$3.54
Value
$76K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About PBYI insider trading
PBYI insider trades
Puma Biotechnology, Inc. (PBYI) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including AUERBACH ALAN H (President and CEO · Director), HUNT DOUGLAS M (See Remarks), NOUGUES MAXIMO F (CFO). Over the past 12 months, 5 insiders have filed transactions with the SEC. PBYI insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Puma Biotechnology, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
PBYI insider trading · 5 questionsThe insiders of Puma Biotechnology, Inc. (PBYI) include executives and directors such as AUERBACH ALAN H (President and CEO · Director), HUNT DOUGLAS M (See Remarks), NOUGUES MAXIMO F (CFO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026